Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | STK39 | Q9UEW8 | 9/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6714042 | 0.86 | AKR1C4 (0.58) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL8980905 | 0.81 | ALDH1A1 (0.55) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL19325989 | 0.81 | NPC1 (0.54) | ALDH1A1POLBHPGD | |
| SCHEMBL19325836 | 0.80 | AKR1C4 (0.55) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL19326233 | 0.79 | CDK1 (0.65) | PTGS1TDP1CA1CA2 | |
| SCHEMBL13320226 | 0.78 | AKR1C4 (0.56) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL3713890 | 0.77 | AKR1C4 (0.60) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL2454782 | 0.76 | AKR1C4 (0.55) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL29548347 | 0.75 | NAAA (0.55) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 | |
| SCHEMBL15887754 | 0.75 | NAAA (0.55) | AKR1C4AKR1C3AKR1C2AKR1C1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | CPN1, HAT1, PRSS1 | AKR1C4 1957/4885AKR1C3 1939/4885AKR1C2 3044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.